Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US cohort: The atherosclerosis risk in communities study cohort

Authors

Michael D. Miedema, Minneapolis Heart Institute Foundation, United States
Faye L. Lopez, University of Minnesota, United States
Michael J. Blaha, Johns Hopkins School of Medicine, United States
Salim S. Virani, Michael E. DeBakey Veterans Affairs Medical Center, United StatesFollow
Josef Coresh, Johns Hopkins Bloomberg School of Public Health, United States
Christie M. Ballantyne, Baylor College of Medicine, United States
Aaron R. Folsom, University of Minnesota, United States

Document Type

Letter to the Editor

Department

Cardiology

Comments

This work was published before the author joined Aga Khan University.

Publication (Name of Journal)

JAMA Internal Medicine

Recommended Citation

Miedema, M. D., Lopez, F. L., Blaha, M. J., Virani, S. S., Coresh, J., Ballantyne, C. M., Folsom, A. R. (2015). Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US cohort: The atherosclerosis risk in communities study cohort. JAMA Internal Medicine, 175(1), 138-140.
Available at: https://ecommons.aku.edu/provost_office/182